Analysis of matrix metalloproteinase (MMP-8 and MMP-2) activity in gingival crevicular fluid from children with Down's syndrome

Journal of Periodontal Research

Volumn 45, Issue 2, 2010, Pages 170-176

  Yamazaki Kubota, T ^a,b   Miyamoto, M ^c   Sano, Y ^a   Kusumoto, M ^d   Yonezu, T ^a   Sugita, K ^e   Okuda, K ^c   Yakushiji, M ^a   Ishihara, K ^b,c  

^a Department of Pediatric Dentistry ^*  (Japan)

^b Tokyo Dental College   (Japan)

^c TOKYO DENTAL COLLEGE   (Japan)

^d NATIONAL INSTITUTE OF ANIMAL HEALTH   (Japan)

^e CHIBA UNIVERSITY   (Japan)

Author keywords

Down's syndrome; Matrix metalloproteinase; Periodontal disease; Subgingival bacterial flora

Indexed keywords

GELATINASE A; MMP2 PROTEIN, HUMAN; MMP8 PROTEIN, HUMAN; NEUTROPHIL COLLAGENASE;

ADOLESCENT; AGGREGATIBACTER ACTINOMYCETEMCOMITANS; ARTICLE; BACTERIAL COUNT; CAMPYLOBACTER RECTUS; CHILD; CLASSIFICATION; DOWN SYNDROME; ENZYMOLOGY; FEMALE; GINGIVA; GINGIVA BLEEDING; GINGIVITIS; HUMAN; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MOUTH HYGIENE; PERIODONTAL POCKET; PERIODONTICS; PORPHYROMONAS GINGIVALIS; TOOTH PLAQUE;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ADOLESCENT; CAMPYLOBACTER RECTUS; CHILD; COLONY COUNT, MICROBIAL; DENTAL PLAQUE; DOWN SYNDROME; FEMALE; GINGIVA; GINGIVAL CREVICULAR FLUID; GINGIVAL HEMORRHAGE; GINGIVAL POCKET; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 8; ORAL HYGIENE INDEX; PERIODONTAL INDEX; PERIODONTAL POCKET; PORPHYROMONAS GINGIVALIS;

EID: 77950224980     PISSN: 00223484     EISSN: 16000765     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2009.01214.x     Document Type: Article

References (44)

1. Desai SS. Down syndrome: a review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997, 84:279-285.
2. Cohen MM, Winer RA, Schwartz S, Shklar G. Oral aspects of mongolism. I. Periodontal disease in mongolism. Oral Surg Oral Med Oral Pathol 1961, 14:92-107.
3. Barnett ML, Press KP, Friedman D, Sonnenberg EM. The prevalence of periodontitis and dental caries in a Down's syndrome population. J Periodontol 1986, 57:288-293.
4. Modeer T, Barr M, Dahllof G. Periodontal disease in children with Down's syndrome. Scand J Dent Res 1990, 98:228-234.
5. Meyle J, Gonzales JR. Influences of systemic diseases on periodontitis in children and adolescents. Periodontol 2000 2001, 26:92-112.
6. Izumi Y, Sugiyama S, Shinozuka O, Yamazaki T, Ohyama T, Ishikawa I. Defective neutrophil chemotaxis in Down's syndrome patients and its relationship to periodontal destruction. J Periodontol 1989, 60:238-242.
7. Nagase H, Visse R, Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 2006, 69:562-573.
8. Sorsa T, Tjaderhane L, Konttinen YT. Matrix metalloproteinases: contribution to pathogenesis, diagnosis and treatment of periodontal inflammation. Ann Med 2006, 38:306-321.
9. Kiili M, Cox SW, Chen HY. Collagenase-2 (MMP-8) and collagenase-3 (MMP-13) in adult periodontitis: molecular forms and levels in gingival crevicular fluid and immunolocalisation in gingival tissue. J Clin Periodontol 2002, 29:224-232.
10. Sorsa T, Uitto VJ, Suomalainen K, Vauhkonen M, Lindy S. Comparison of interstitial collagenases from human gingiva, sulcular fluid and polymorphonuclear leukocytes. J Periodontal Res 1988, 23:386-393.
11. Imai K, Ohta S, Matsumoto T. Expression of membrane-type 1 matrix metalloproteinase and activation of progelatinase A in human osteoarthritic cartilage. Am J Pathol 1997, 151:245-256.
12. Aimes RT, Quigley JP. Matrix metalloproteinase-2 is an interstitial collagenase. Inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3/4- and 1/4-length fragments. J Biol Chem 1995, 270:5872-5876.
13. Konttinen YT, Ceponis A, Takagi M. New collagenolytic enzymes/cascade identified at the pannus-hard tissue junction in rheumatoid arthritis: destruction from above. Matrix Biol 1998, 17:585-601.
14. Birkedal-Hansen H, Moore WG, Bodden MK. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 1993, 4:197-250.
15. Ingman T, Sorsa T, Lindy O, Koski H, Konttinen YT. Multiple forms of gelatinases/type IV collagenases in saliva and gingival crevicular fluid of periodontitis patients. J Clin Periodontol 1994, 21:26-31.
16. Makela M, Salo T, Uitto VJ, Larjava H. Matrix metalloproteinases (MMP-2 and MMP-9) of the oral cavity: cellular origin and relationship to periodontal status. J Dent Res 1994, 73:1397-1406.
17. Korostoff JM, Wang JF, Sarment DP, Stewart JC, Feldman RS, Billings PC. Analysis of in situ protease activity in chronic adult periodontitis patients: expression of activated MMP-2 and a 40 kDa serine protease. J Periodontol 2000, 71:353-360.
18. Ejeil AL, Igondjo-Tchen S, Ghomrasseni S, Pellat B, Godeau G, Gogly B. Expression of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in healthy and diseased human gingiva. J Periodontol 2003, 74:188-195.
19. Sorsa T, Ding YL, Ingman T. Cellular source, activation and inhibition of dental plaque collagenase. J Clin Periodontol 1995, 22:709-717.
20. Halinen S, Sorsa T, Ding Y. Characterization of matrix metalloproteinase (MMP-8 and -9) activities in the saliva and in gingival crevicular fluid of children with Down's syndrome. J Periodontol 1996, 67:748-754.
21. Komatsu T, Kubota E, Sakai N. Enhancement of matrix metalloproteinase (MMP)-2 activity in gingival tissue and cultured fibroblasts from Down's syndrome patients. Oral Dis 2001, 7:47-55.
22. Amano A, Kishima T, Kimura S. Periodontopathic bacteria in children with Down syndrome. J Periodontol 2000, 71:249-255.
23. Barr-Agholme M, Dahllof G, Linder L, Modeer T. Actinobacillus actinomycetemcomitans, Capnocytophaga and Porphyromonas gingivalis in subgingival plaque of adolescents with Down's syndrome. Oral Microbiol Immunol 1992, 7:244-248.
24. Soder B, Airila Mansson S, Soder PO, Kari K, Meurman J. Levels of matrix metalloproteinases-8 and -9 with simultaneous presence of periodontal pathogens in gingival crevicular fluid as well as matrix metalloproteinase-9 and cholesterol in blood. J Periodontal Res 2006, 41:411-417.
25. Yamazaki T, Miyamoto M, Yamada S, Okuda K, Ishihara K. Surface protease of Treponema denticola hydrolyzes C3 and influences function of polymorphonuclear leukocytes. Microbes Infect 2006, 8:1758-1763.
26. Greene JC, Vermillion JR. The oral hygiene index. A method for classifying oral hygiene status. J Am Dent Assoc 1960, 61:172-179.
27. Ashimoto A, Chen C, Bakker I, Slots J. Polymerase chain reaction detection of 8 putative periodontal pathogens in subgingival plaque of gingivitis and advanced periodontitis lesions. Oral Microbiol Immunol 1996, 11:266-273.
28. Kobayashi N, Ishihara K, Sugihara N, Kusumoto M, Yakushiji M, Okuda K. Colonization pattern of periodontal bacteria in Japanese children and their mothers. J Periodontal Res 2008, 43:156-161.
29. Reuland-Bosma W, van Dijk J. Periodontal disease in Down's syndrome: a review. J Clin Periodontol 1986, 13:64-73.
30. Alfant B, Shaddox LM, Tobler J, Magnusson I, Aukhil I, Walker C. Matrix metalloproteinase levels in children with aggressive periodontitis. J Periodontol 2008, 79:819-826.
31. Egelberg J. Permeability of the dento-gingival blood vessels. IV. Effect of histamine on vessels in clinically healthy and chronically inflamed gingivae. J Periodontal Res 1966, 1:297-302.
32. Pirhan D, Atilla G, Emingil G, Sorsa T, Tervahartiala T, Berdeli A. Effect of MMP-1 promoter polymorphisms on GCF MMP-1 levels and outcome of periodontal therapy in patients with severe chronic periodontitis. J Clin Periodontol 2008, 35:862-870.
33. Grayson R, Douglas CW, Heath J, Rawlinson A, Evans GS. Activation of human matrix metalloproteinase 2 by gingival crevicular fluid and Porphyromonas gingivalis. J Clin Periodontol 2003, 30:542-550.
34. Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 2003, 92:827-839.
35. Bodet C, Andrian E, Tanabe S, Grenier D. Actinobacillus actinomycetemcomitans lipopolysaccharide regulates matrix metalloproteinase, tissue inhibitors of matrix metalloproteinase, and plasminogen activator production by human gingival fibroblasts: a potential role in connective tissue destruction. J Cell Physiol 2007, 212:189-194.
36. Andrian E, Mostefaoui Y, Rouabhia M, Grenier D. Regulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases by Porphyromonas gingivalis in an engineered human oral mucosa model. J Cell Physiol 2007, 211:56-62.
37. Garlet GP, Cardoso CR, Silva TA. Cytokine pattern determines the progression of experimental periodontal disease induced by Actinobacillus actinomycetemcomitans through the modulation of MMPs, RANKL, and their physiological inhibitors. Oral Microbiol Immunol 2006, 21:12-20.
38. Page RC. The role of inflammatory mediators in the pathogenesis of periodontal disease. J Periodontal Res 1991, 26:230-242.
39. Shenker BJ, Slots J. Immunomodulatory effects of Bacteroides products on in vitro human lymphocyte functions. Oral Microbiol Immunol 1989, 4:24-29.
40. Shenker BJ, McKay T, Datar S, Miller M, Chowhan R, Demuth D. Actinobacillus actinomycetemcomitans immunosuppressive protein is a member of the family of cytolethal distending toxins capable of causing a G2 arrest in human T cells. J Immunol 1999, 162:4773-4780.
41. Cuadrado E, Barrena MJ. Immune dysfunction in Down's syndrome: primary immune deficiency or early senescence of the immune system? Clin Immunol Immunopathol 1996, 78:209-214.
42. Gregory L, Williams R, Thompson E. Leucocyte function in Down's syndrome and acute leukaemia. Lancet 1972, 1:1359-1361.
43. Ishikawa I, Nakashima K, Koseki T. Induction of the immune response to periodontopathic bacteria and its role in the pathogenesis of periodontitis. Periodontol 2000 1997, 14:79-111.
44. Bildt MM, Bloemen M, Kuijpers-Jagtman AM, Von den Hoff JW. Collagenolytic fragments and active gelatinase complexes in periodontitis. J Periodontol 2008, 79:1704-1711.